Student Competition

RESULTS UK and Student Stop AIDS Campaign invite you to take part in our exciting new competition to find the best in emerging global health journalism!

The competition: Students must submit a piece of original reporting on the themes of TB, HIV or TB-HIV coinfection in a new or innovative manner. Entries must be no longer than 1000 words long. The work will be judged on its advocacy potential. We are looking for inspirational and informative work! The deadline for the competition is 30 November 2011.

From a shortlist of five, one winner and four runner ups will be chosen and announced on Monday 5 December 2011.

The winning candidate will join the RESULTS UK delegation on an all expenses paid trip to South Africa with UK Parliamentarians and UK grassroots activists in February 2012, to learn and see firsthand the devastating impact of tuberculosis (TB) and HIV on families and communities in the developing world.

Please click here for Terms and Conditions and for more information on how to join the competition. For further information on how to apply please contact Amy Sheppey at RESULTS UK via email amy.sheppey@results.org.uk or telephone on 020 7499 8238.

So, why South Africa?

TB and HIV/AIDS are public health emergencies in Africa. These diseases unnecessarily kill hundreds of thousands of people worldwide each year. In 2009 1.7 million people died from TB, including almost 400,000 people with HIV. South Africa accounts for 28 per cent of the world’s people living with both HIV and TB and is addressing these major health challenges using new and innovative integration tools, to fight ONE epidemic of TB/HIV coinfection.

This year South Africa will be one of the very first countries to roll out the GeneXpert machine, an innovative new tool able to diagnose tuberculosis and drug resistant strains including within HIV positive populations in under two hours, revolutionising the way in which we are able to diagnose TB and treat at a rate never before possible. South Africa presents a unique opportunity to see how the battle against TB/HIV is being fought and won.